Mergers & Acquisitions Mergers & Acquisitions

Illumina under EU investigation for jumping the gun in Grail merger review

By Natalie McNelis and Nicholas Hirst
  • 20 Aug 2021 05:16
  • 20 Aug 2021 05:30
Illumina will come under investigation for its decision to close its Grail deal before receiving EU approval, the European Commission confirmed today.

The US gene-sequencing company said on Wednesday that it had finalized the acquisition (see here) despite ongoing merger reviews in the US and Europe, saying the agreement would otherwise expire before regulators

To view the latest version of this document and thousands of others like it, sign-in to MLex or register for a free trial.

Discover MLex

Stay on top of global regulatory developments


Latest News